戴维医疗 (300314.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(戴维医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 141,652,892.68159,445,978.47157,862,759.12156,249,587.93140,779,306.15111,292,296.1797,715,502.09
 营业收入(元) 141,652,892.68159,445,978.47157,862,759.12156,249,587.93140,779,306.15111,292,296.1797,715,502.09
二、营业总成本(元) 113,533,103.24118,679,195.92110,973,756.29141,065,697.9593,049,363.1785,391,003.1577,461,419.14
 营业成本(元) 62,887,192.0065,445,981.6364,319,864.2569,708,369.5754,170,135.6347,643,831.9238,217,606.86
 研发费用(元) 10,334,404.218,487,128.998,627,320.9719,191,723.9310,081,994.858,871,747.147,723,486.29
 营业税金及附加(元) 1,181,236.922,806,886.171,662,988.082,947,715.731,120,175.342,831,357.661,083,736.72
 销售费用(元) 28,422,572.2342,738,153.9721,132,671.7739,928,639.7127,504,362.3225,615,133.0118,519,136.59
 管理费用(元) 13,211,065.2413,344,174.6415,464,689.527,480,085.7213,198,507.3411,167,800.4811,777,532.71
 财务费用(元) -2,503,367.36-14,143,129.48-233,778.301,809,163.29-13,025,812.31-10,738,867.06139,919.97
  其中:利息费用(元) 138,065.89156,779.69155,548.33169,142.84170,876.355,171.845,116.01
  其中:利息收入(元) 3,506,625.854,070,728.392,988,975.652,227,273.061,628,150.36866,035.05672,587.13
 信用减值损失(元) -524,663.95-137,196.95-473,723.97-154,504.81-909,643.56-159,436.317,922.71
三、其他经营收益
 加:投资收益(元) 886,980.463,341,996.546,596,225.754,769,391.18-1,658,466.963,626,462.33-12,519,228.93
  其中:对联营企业和合营企业的投资收益(元) -1,312,875.52782,124.644,754,526.152,796,357.07-5,021,232.29764,950.83-15,041,621.53
 资产处置收益(元) 4,487.86-287,493.261,539.607,430.70---
 其他收益(元) 6,653,674.812,461,598.674,867,363.371,024,580.601,052,450.001,474,751.395,993,585.32
四、营业利润(元) 35,140,268.6246,145,687.5557,880,407.5821,208,639.4746,214,282.4630,850,881.0213,736,362.05
 加:营业外收入(元) 17,538.8515,087.489,408.413,468.227,588.7020,687.33745.87
 减:营业外支出(元) 41,372.4457,109.9493,889.724,123.8228,203.53-112,640.86207,065.15
五、利润总额(元) 35,116,435.0346,103,665.0957,795,926.2721,207,983.8746,193,667.6330,984,209.2113,530,042.77
 减:所得税费用(元) 4,097,923.184,346,153.387,776,638.78-371,645.926,112,441.354,654,247.543,943,231.38
六、净利润(元) 31,018,511.8541,757,511.7150,019,287.4921,579,629.7940,081,226.2826,329,961.679,586,811.39
(一)按经营持续性分类
  持续经营净利润(元) 31,018,511.8541,757,511.7150,019,287.4921,579,629.7940,081,226.2826,329,961.679,586,811.39
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 31,018,511.8541,757,511.7150,019,287.4921,579,629.7940,081,226.2826,329,961.679,586,811.39
 扣除非经常性损益后的净利润(元) 23,543,541.3737,769,350.0944,387,084.4218,266,852.3836,345,815.8522,524,170.252,523,601.55
七、每股收益
 一、基本每股收益(元) 0.110.150.170.080.140.090.03
 二、稀释每股收益(元) 0.110.150.170.080.140.090.03
九、综合收益总额(元) 31,018,511.8541,757,511.7150,019,287.4921,579,629.7940,081,226.2826,329,961.679,586,811.39
 归属于母公司所有者的综合收益总额(元) 31,018,511.8541,757,511.7150,019,287.4921,579,629.7940,081,226.2826,329,961.679,586,811.39
公告日期 2023-10-252023-08-222023-04-212023-03-312022-10-252022-08-242022-04-22
审计意见(境内) 标准无保留意见

前瞻产业研究院